Infinity Holdings has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Infinity Holdings, an entity associated with Jagsonpal Pharmaceuticals, has submitted a disclosure to the stock exchange under Regulation 31(4) of SEBI's Substantial Acquisition of Shares and Takeovers Regulations, 2011. This regulation pertains to the disclosure of details regarding encumbered (pledged or otherwise encumbered) shares held by promoters or persons acting in concert. The filing does not specify the exact nature of the disclosure — whether it involves creation of a new pledge, invocation of an existing pledge, or release of encumbrance. No specific share quantities, percentages, or transaction values have been disclosed in this headline.
This appears to be a routine regulatory compliance filing. Until the actual details of the disclosure (such as pledge creation, invocation, or release and the quantum involved) are made available, shareholders cannot determine any concrete impact on promoter holdings or the stock price.